Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension

Journal of Human Hypertension volume 21, pages 546–550 (2007)Cite this article

Abstract

Hypertension is frequently associated with obesity and natriuretic peptide levels are reported to decrease in obese subjects. Both the lower brain natriuretic peptide (BNP) concentration and insulin resistance are suggested to be associated with hypertension. However, their involvement in obesity-related hypertension has not been clearly defined. Forty-four obese women (21 normotensive and 23 hypertensive) and 25 healthy women matched for age were included in the study. Anthropometrical parameters were determined. Serum BNP, fasting insulin and glucose concentrations, and lipid parameters were evaluated. Insulin resistance was calculated using Homeostasis Model Assessment (HOMA) and Quantative Insulin Sensitivity Check Index (QUICKI) formulations. Within the obese groups, HOMA and QUICKI reflected the increased insulin resistance in hypertensive obese subjects with a significant correlation to blood pressure. The decrease in BNP in the obese groups was in favour of the hypertensive obese subjects (31.43±6.43; 26.36±4.29; and 17.51±3.08 pg/ml, respectively) with a fractional statistical significance between the hypertensive obese group and the controls (P=0.047). Only for the obese hypertensive group, fasting glucose, HOMA and QUICKI were significantly correlated with BNP. Moreover, fasting plasma glucose (R2=0.22, P=0.007) and fasting plasma insulin (R2=0.39, P=0.03) were independently correlated with BNP only for the obese hypertensive group. It can be concluded that the decrease in BNP concentrations in the obese hypertensive subjects seem to be well correlated with the insulin resistance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005; 112: 2163–2168.

    Article  CAS  Google Scholar 

  2. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M . Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients. Am Heart J 1998; 135: 825–832.

    Article  CAS  Google Scholar 

  3. Hammerer-Lercher A, Neubauer E, Muller S, Pachineger O, Puschhendorf B, Mair J . Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310: 193–197.

    Article  CAS  Google Scholar 

  4. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594–600.

    Article  CAS  Google Scholar 

  5. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC et al. Obesity and supresssed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590–1595.

    Article  CAS  Google Scholar 

  6. McCord J, Mundy BJ, Hudson MP . Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004; 164: 2247–2252.

    Article  CAS  Google Scholar 

  7. Dessi-Fulgheri P, Paci MV, Tamburrini P, Moraca A, Espinosa E, Cola G et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 1997; 15: 1695–1699.

    Article  CAS  Google Scholar 

  8. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA . Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993; 7: 245–250.

    CAS  PubMed  Google Scholar 

  9. Reaven GM, Lithell H, Landsberg L . Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374–381.

    Article  CAS  Google Scholar 

  10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes 1985; 28: 412–419.

    CAS  Google Scholar 

  12. Katz A, Nambii SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–2410.

    Article  CAS  Google Scholar 

  13. World Health Report. Reducing Risks, Promoting Healthy Life. World Health Orgaization: Geneva, Switzerland, 2002.

  14. Schillaci G, Pasqualini L, Vaudo G, Lupattelli G, Pirro M, Gemelli F et al. Effect of body weight changes on 24-h blood pressure and left ventricular mass in hypertension: a 4-year follow-up. Am J Hypertens 2003; 16: 634–639.

    Article  Google Scholar 

  15. Sarzani R, Dessi-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999; 17: 1301–1305.

    Article  CAS  Google Scholar 

  16. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Kato Y, Saruta T . Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects. J Hum Hypertens 2001; 15: 393–399.

    Article  CAS  Google Scholar 

  17. Tanabe A, Naruse M, Wasada T, Naruse K, Yoshimoto T, Omori Y et al. Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur J Endocrinol 1995; 132: 693–698.

    Article  CAS  Google Scholar 

  18. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22–30.

    Article  CAS  Google Scholar 

  19. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992; 92: 29–34.

    Article  CAS  Google Scholar 

  20. Conen D, Pfisterer M, Martina B . Substantial intraindividual variability of BNP concentrations in patients with hypertension. J Hum Hypertens 2006; 20: 387–391.

    Article  CAS  Google Scholar 

  21. Bruins SM, Fokkema R, Römer JWP, DeJongste MJL, van der Dijs FPL, van den Ouweland JMW et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004; 50: 2052–2058.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, School of Medicine, Inonu University, Malatya, Turkey

    S Tekes

  2. Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Inonu University, Malatya, Turkey

    A S Cikim

Authors
  1. S Tekes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A S Cikim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A S Cikim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tekes, S., Cikim, A. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension. J Hum Hypertens 21, 546–550 (2007). https://doi.org/10.1038/sj.jhh.1002194

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002194

Keywords

This article is cited by

Search

Advanced search

Quick links